IC
JAZZ icon

IEQ Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

IEQ Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$716K Buy
3,788
+646
+21% +$113K ﹤0.01% 1155
2025
Q4 		$534K Buy
+3,142
New +$482K ﹤0.01% 1304
2025
Q3 		– Sell
-3,970
Closed -$421K – 1966
2025
Q2 		$421K Buy
+3,970
New +$431K ﹤0.01% 1242

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

IEQ Capital's JAZZ Position: Q1 2026 in Review

IEQ Capital increased its Jazz Pharmaceuticals (JAZZ) stake by 21% in Q1 2026, buying an estimated $113K and bringing the position to 3,788 shares worth $716K. The position accounts for ﹤0.01% of the portfolio, ranked #1155.

IEQ Capital first reported a position in JAZZ in Q2 2025 and has held it in 3 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • IEQ Capital held 3,788 shares of Jazz Pharmaceuticals worth $716K as of Q1 2026.
  • IEQ Capital bought 646 Jazz Pharmaceuticals shares in Q1 2026, an estimated $113K.
  • Jazz Pharmaceuticals made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1155 holding.
  • IEQ Capital first reported a position in Jazz Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.